SENSEX NIFTY

Pharma

Nov 26, 2014 at 15:22 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Ambuja Cements, Sun Pharma and Mindtree.
Nov 26, 2014 at 14:26 | Source: Moneycontrol.com
Brokerage house Motilal Oswal is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 873, in its research report dated October 31, 2014.
Nov 26, 2014 at 12:49 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Torrent Power, GVK, Reliance Power, GMR Infrastructure, ITC, Aurobindo Pharma, Puravankara, HMT and Bharti Airtel.
Nov 26, 2014 at 12:19 | Source: PTI
The Hyderabad-based firm features among the top ten companies in India in terms of consolidated revenues. It exports to over 125 countries across the globe with more than 70 percent of its revenues derived out of international operations.
Nov 26, 2014 at 11:50 | Source: CNBC-TV18
Sashi Krishnan is overweight on banking and financial sector. Among other sectors, he is bullish on pharmaceuticals and IT
Nov 26, 2014 at 11:01 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Glenmark Pharma, Sun Pharma, Cipla, Biocon and Dr Reddys Lab's will be getting astrological support.
Nov 26, 2014 at 10:41 | Source: Moneycontrol.com
Equity Mutual Funds declined as the Indian equities fell a day after markets raced to a fresh high, with the Sensex falling 161 points, the biggest single-day fall in nearly six weeks.
Nov 26, 2014 at 10:38 | Source: CNBC-TV18
Amit Gupta of ICICI Direct feels that Glenmark Pharma may go upto Rs 900-950.
Nov 26, 2014 at 08:24 | Source: Moneycontrol.com
Stocks in news: GMR | MRF | Financial Technologies | Greenply industries | South Indian Bank | DLF | Omaxe | Aurobindo Pharma and Tata Coffee are stocks | which are in news today.
Nov 25, 2014 at 21:55 | Source: Moneycontrol.com
Aurobindo Pharma in its Meeting held on November 25, 2014, has considered and approved raising of the funds by the Company through Issue of Securities upto an amount of USD 350 Million or Rupee equivalent thereof through follow on offer, qualified institutions placement, further public offer.
Messages on Pharma »

subs74

Silver Member

3 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th

jagoinvesto
r

Platinum Member

113 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th

JPInvestor

New Member

0 Follower

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th

shmarketgen
ius

Platinum Member

591 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th

countryman

Platinum Member

628 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th

News across the web »
Nov 25, 2014 at 13:02 | Source: Calcutta Telegraph News
Nov 25, 2014 at 05:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.